Both andexanet alfa and four‐factor prothrombin complex concentrate (4f‐pcc) are clinically applied reversal agents for direct factor xa inhibitors (fxais) in emergency situations. Controversy exists … This document provides recommendations for reversing anticoagulants in patients with bleeding complications.